100
Participants
Start Date
March 24, 2023
Primary Completion Date
February 24, 2028
Study Completion Date
February 24, 2030
Durvalumab
Patients showing a disease control (defined as stable disease \[SD\], partial response \[PR\], or complete response \[CR\] according to RECIST v1.1) at the radiological evaluation performed after the end of thoracic CRT will receive durvalumab intravenously 1500 mg every 4 weeks until disease progression, unacceptable toxicity, death or patient's decision for a maximum of 24 months.
ACTIVE_NOT_RECRUITING
Centre de Radiothérapie du Pays d'Aix, Aix-en-Provence
RECRUITING
Centre Hospitalier du Pays d'Aix, Aix-en-Provence
RECRUITING
Institut du Cancer Avignon-Provence, Avignon
ACTIVE_NOT_RECRUITING
Centre d'Oncologie du Pays Basque, Bayonne
RECRUITING
CH de la côte Basque, Bayonne
NOT_YET_RECRUITING
Clinique Belharra, Bayonne
RECRUITING
Centre François Baclesse, Caen
RECRUITING
CHU de CAEN, Caen
RECRUITING
Centre Jean Perrin, Clermont-Ferrand
RECRUITING
CHI Créteil, Créteil
RECRUITING
Centre George François Leclerc, Dijon
RECRUITING
Centre Oscar Lambret, Lille
RECRUITING
CHU Dupuytren, Limoges
RECRUITING
Polyclinique de Limoges -Site Clinique Chénieux, Limoges
RECRUITING
Groupe Hospitalier Bretagne Sud, Lorient
NOT_YET_RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
APHM - Hôpital Nord, Marseille
RECRUITING
Hopital européen Marseille, Marseille
ACTIVE_NOT_RECRUITING
Hopital privé Clairval, Marseille
RECRUITING
Institut Paoli-Calmettes, Marseille
RECRUITING
Institut régional du Cancer de Montpellier - ICM Val d'Aurelle, Montpellier
RECRUITING
Hopital privé du Confluent, Nantes
NOT_YET_RECRUITING
Centre Lacassagne, Nice
RECRUITING
Hôpital Tenon APHP, Paris
RECRUITING
Institut Curie, Paris
ACTIVE_NOT_RECRUITING
CARIO, Plérin
RECRUITING
Institut Godinot, Reims
RECRUITING
Centre Henri Becquerel, Rouen
RECRUITING
CH Saint Brieuc, Saint-Brieuc
NOT_YET_RECRUITING
Clinique Mutualiste de l'Estuaire, Saint-Nazaire
NOT_YET_RECRUITING
Centre d'oncologie Saint Yves, Vannes
RECRUITING
Hopital Nord Ouest - Villefranche sur Saône, Villefranche-sur-Saône
Collaborators (1)
AstraZeneca
INDUSTRY
UNICANCER
OTHER